ABSTRACT The Global Fund Secretariat presented its update on country funding to the 46th Board meeting just held in early November. As of 20 October 2021, 186 out of 200 Funding Requests reviewed in Windows 1-6 had been recommended for grant-making.
The Secretariat presented the 46th Global Fund Board meeting with an Update on Country Funding. We look first at the picture painted by this Country Funding Update, and then we discuss the Global Fund’s financial performance as of 30th June 2021, presented to the 46th Board meeting for information.
This article is based on the slide deck presented at the Board meeting, with the latest picture regarding expenditures taken from the Board paper, Financial Performance as of 30th June 2021.
Portfolio optimization is one of the ways in whichtnvestment and portfolio management. In the normal course of grant management, the Global Fund Secretariat and partners work together continuously with countries to address the root causes of bottlenecks in implementation. As a first step to use funds to their best purposes in portfolio optimization, countries can actively reprogram potentially unutilized funds within the same country disease component throughout the grant lifecycle, including towards priorities registered as unfunded quality demand (UQD). Countries with implementation challenges or barriers to scale-up are not penalized in the implementation of the prioritization framework: individual grants with low absorption will retain the possibility of catching up with spending and programmatic activities until the end of their grant implementation period.
As of the end of June this year, the Fund’s financial performance was deemed to be positive and hence the Audit and Finance Committee (AFC) had approved $100 million to be made available for portfolio optimization. Usually, the Update on Country Funding and Portfolio Optimization would also include a progress report on Portfolio Optimization (PO) but there have been no new PO decisions in 2021, therefore no information about this was included in the update.
As of 20 October 2021, 186 out of 200 Funding Requests reviewed in Windows 1-6 by the Technical Review Panel (TRP) had been recommended for grant-making, with a 7% iteration rate ― when the TRP requests that a funding request be revised and resubmitted ― across all reviews completed. Eight country applications are expected for review in 2022. See Figure 1.
By the end of 2020, the Board had approved 164 new grants and, by the end of October 2021, 70 new grants were additionally approved by the Board. About 34 new grants are still expected to be reviewed and approved in 2021, with about a further 24 expected in 2022. This projection is based on the end-dates of current grants.
Of the $230 million designated for Multi-country Funds (see Figure 7), $144 million was integrated into Board-approved grants by end-October 2021. Grants for the remaining priority areas are in development.
This may be for several reasons but it is most likely due to countries having a good grant absorption rate or contributory factors such as the flexibilities and reprogramming allowed for COVID-19 impact mitigation.
, primarily driven by contributions to the COVID-19 Response Mechanism (C19RM) and moderated by risk adjustments (+ $3,634 million since January 2021). The position performance of
generated $183 million of net gains over the cycle. This is composed of +$36 million from active
hedging (- $3 million since AFC’s 16th (AFC16) meeting) and + $148M of
(+ $41 M since AFC16).
Regular HTM grant disbursements: at $2.1 billion ($1.5 billion for the 6th cycle and $0.6 billion for the 5th), they were 12% higher than actual disbursements in the first half of 2020 at $1.9 billion. This strong in-country performance, with an absorption of 83% for the 5th funding cycle grants, is in line with the Secretariat’s target and represents an achievement of the ICA target of 85% confirmed – considering the agreed margin of +/- 4-5%.
The ICA was maintained at a high level despite the COVID-19 context thanks to program adaptions ― +8% above the Board-approved key performance indicator (KPI) of 75%. Higher in-country absorption is at 87% for grants ended up to December 2020 (closure is still ongoing), i.e., 12% above the Board-approved KPI. The Secretariat is continuously integrating improvements and alignment of programmatic and financial performance in the ongoing 6th replenishment grants.
Delayed utilization of SI funds in the first half of 2021 has resulted in a forecasted fund utilization of 83% (Figure 11). The lower forecast was driven by first-year delays in approval, contracting, and bringing the workforce on board ($13 million of actuals at the end of June or 4% of the total envelope).
For the 2020-2022 cycle, $268 million or 83% fund utilization (out of which $13M are actuals and $255 million are remaining Forecast) down from 94% in the previous forecast. Implementation delays have been affected by stricter funding reviews and extended contracting efforts including negotiations with technical partners on partnership agreements and bringing staff on board; $55 million is expected to remain unused by the end of the cycle or 83% SI utilization. This situation will be reassessed after the end of year 1, including a review of reprogramming and reallocation or reinvestment opportunities.
By the end of June 2021, there had been a cumulative $13 million or 4% fund utilization. The implementation of partner-managed SIs had still not started. However, some initiatives like CCM Evolution and CRG had benefited from an early start and/or continuation of activities. The AFC noted that for directly managed SI, acceleration in contracting will be key to catching up.
)
The OPEX Forecast shows an overall budget execution of 98 % for 2021, in line with the half-year actuals given the COVID19 disruptions. It is expected to be at $309 million below the 2021 Budget: the first half-year actual execution of $137 million (43% of the 2021 Budget) and accelerated spending forecasted in the second half-year of $172M (55%) – 98% of Budget execution at the end of the year. See our separate article
.
There has been a strong acceleration for C19RM 2021 related processes
In September 2020, after eight months 80% of awards had been granted based on the impact of COVID-19 on implementers’ abilities to rapidly execute and provide timely reporting in the current context. The Global Fund took one of its infamous ‘deep dives’ into C19RM to provide an analysis based on High Impact and Core Countries representing 90% of investments. The updated in-country utilization estimates of $565 million for Hi/Core countries resulted in a utilization rate of 63% as of 30 June 2021. 90% of expenditure estimates ($507 million) were based on validated reports or were still being verified by Local Fund Agents. The analysis found that challenges in the supply chain pipeline impacted the timely delivery of products: delays encountered for products valued at $57 million with an expected June delivery date. The 63% to 70% utilization for an average of six-eight months of in-country execution of a new initiative is above the historical Secretariat trend for HTM grants and SIs.
As noted above, $100 million was approved for portfolio optimization. The AFC suggested that the Secretariat consider providing an additional focus on technical assistance to Principal Recipients (PRs) and insights on Strategic Initiatives.
The Board Document GF/B46/16, Financial Performance as at 30th June 2021. should be available shortly at https://www.theglobalfund.org/en/board/meetings/46.
No comments yet. Be the first to comment!